• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    A Role for microRNA-34a In Regulating CD8alpha+ Dendritic Cell Function

    Thumbnail
    Date
    2015
    Author
    Furtado, Raquel M.
    Metadata
    Show full item record
    Abstract
    Dendritic cells (DCs) play an important role in regulating innate and adaptive immune responses. The CD8alpha+ DC subset is highly efficient at antigen cross presentation and thereby capable of modulating CD8+ T cell activity. In the context of DC activation via ligation of toll-like receptors (TLRs), pathogen-derived antigens are cross-presented on the DCs resulting in CD8+ T cell differentiation into effector cells. One recently identified mechanism for regulation of TLR responses is via microRNAs (miRNAs), which are short non-coding RNAs that regulate gene expression through the RNA interference (RNAi) pathway. While a small set of miRNAs has been linked to DC development and maturation, miRNA regulation of CD8alpha+ DCs has not been investigated.;We generated in vitro cultures of CD8alpha +-like bone marrow derived dendritic cells (CD8alpha+L- BMDCs) that are functionally equivalent to splenic CD8alpha+ DCs. When activated with TLR9 agonist (CpG ODN 1826), these CD8alpha +L-BMDCs express a distinct miRNA signature. We found that miR-34a is highly upregulated in TLR9 activated CD8alpha+L- BMDCs and splenic CD8alpha+ DCs, but not in CD8alpha-L- BMDCs and splenic CD11 b+ CD8alpha+ DCs. Additionally, TLR9 expression is required for miR-34a upregulation by splenic CD8alpha + DCs in response to TLR9 agonist.;Using a miR-34a KO mouse we found that in vitro differentiation, expression of co-stimulatory molecules and production of cytokines and chemokines is comparable in miR-34a KO and wildtype CD8alpha+L- BMDCs in response to TLR9 agonist. However, we observed increased proliferation and activation of OT-I CD8+ T cells cross-primed by ovalbumin loaded miR-34a KO CD8alpha+L- BMDCs. We observed enhanced IL-12 production and increased expression of CD86 by splenic CD8alpha + DCs in miR-34a KO mice after systemic injection of TLR9 agonist. Increased inflammatory cytokine production by cross-primed OT-1 CD8 +T cells in miR-34a KO mice was observed in vivo. These data suggest a role for miR-34a in regulating the function of splenic CD8alpha+ DCs.
    Permanent Link(s)
    https://yulib002.mc.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10024020
    https://hdl.handle.net/20.500.12202/366
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University